Form4insider filings, from the source

SEC Form 3 · accession 0001710420-17-000003

Avant Diagnostics, Inc · AVDX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jun 19, 2017
Accepted (ET)
Jun 28, 2017 · 4:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001451929

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stockholding———13,283,333IThrough Infusion 51a, LP
Common Stockholding———4,075,000IThrough International Infusion, LP

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Senior Secured Convertible Promissory Notes$0.15holding———Nov 16, 2016Jan 15, 2018Common Stock——I
Senior Secured Convertible Promissory Notes$0.15holding———Dec 2, 2016Jan 15, 2018Common Stock——I
Senior Secured Convertible Promissory Notes$0.15holding———Dec 6, 2016Jan 15, 2018Common Stock——I
Senior Secured Convertible Promissory Notes$0.15holding———Dec 12, 2016Jan 15, 2018Common Stock——I
Senior Secured Convertible Promissory Notes$0.15holding———Dec 13, 2016Jan 15, 2018Common Stock——I
Senior Secured Convertible Promissory Notes$0.15holding———Nov 16, 2016Jan 15, 2018Common Stock——I
Senior Secured Convertible Promissory Notes$0.15holding———Dec 23, 2016Jan 15, 2018Common Stock——I
WarrantsF1$0.06holding———Jun 19, 2017Jun 19, 2022Common Stock10,833,333—I
Common Stock Purchase RightsF2$0.06holding———Jan 19, 2019Jun 19, 2022Common Stock43,333,333—I
Senior Secured Convertible Promissory Notes$0.06holding———Jun 19, 2017Jun 19, 2020Common Stock——I

Explanation of responses